These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9888257

  • 1. Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction.
    Duarte J, Lugnier C, Torres AI, Pérez-Vizcaino F, Zarzuelo A, Tamargo J.
    Gen Pharmacol; 1999 Jan; 32(1):71-4. PubMed ID: 9888257
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
    Stehlik J, Movsesian MA.
    Expert Opin Investig Drugs; 2006 Jul 15; 15(7):733-42. PubMed ID: 16787138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.
    O'Donnell JM, Frith S.
    Pharmacol Biochem Behav; 1999 May 15; 63(1):185-92. PubMed ID: 10340540
    [Abstract] [Full Text] [Related]

  • 7. Endothelium-independent and endothelium-dependent vasorelaxation by a dichloromethane fraction from Anogeissus Leiocarpus (DC) Guill. Et Perr. (Combretaceae): possible involvement of cyclic nucleotide phosphodiesterase inhibition.
    Belemnaba L, Ouédraogo S, Auger C, Chataigneau T, Traore A, Guissou IP, Lugnier C, Schini-Kerth VB, Bucher B.
    Afr J Tradit Complement Altern Med; 2013 May 15; 10(2):173-9. PubMed ID: 24146440
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells.
    Ashikaga T, Strada SJ, Thompson WJ.
    Biochem Pharmacol; 1997 Nov 15; 54(10):1071-9. PubMed ID: 9464449
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC.
    Biochem Pharmacol; 1987 Nov 15; 36(22):3965-72. PubMed ID: 2825708
    [Abstract] [Full Text] [Related]

  • 14. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ, Cairrão E, Morgado M, Alvarez E, Verde I.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):102-9. PubMed ID: 18234184
    [Abstract] [Full Text] [Related]

  • 15. The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity.
    Elliott KR, Berry JL, Bate AJ, Foster RW, Small RC.
    J Enzyme Inhib; 1991 Mar 17; 4(3):245-51. PubMed ID: 1645399
    [Abstract] [Full Text] [Related]

  • 16. Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins.
    Nichols MR, Morimoto BH.
    Mol Pharmacol; 2000 Apr 17; 57(4):738-45. PubMed ID: 10727520
    [Abstract] [Full Text] [Related]

  • 17. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS, Bercovici A, Boykow G, Bronnenkant A, Chackalamannil S, Chow J, Cleven R, Cook J, Czarniecki M, Domalski C, Fawzi A, Green M, Gündes A, Ho G, Laudicina M, Lindo N, Ma K, Manna M, McKittrick B, Mirzai B, Nechuta T, Neustadt B, Puchalski C, Pula K, Zhang H.
    J Med Chem; 1997 Jul 04; 40(14):2196-210. PubMed ID: 9216839
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ, England PJ.
    Biochem Soc Trans; 1992 May 04; 20(2):460-4. PubMed ID: 1327922
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.